I Support Benlysta....and I Don't Have Lupus

I Support Benlysta….and I Don’t Have Lupus

Benlysta is the first new drug approved for Lupus in 50 years. It's not for everyone with Lupus, but for those who can benefit, that's awesome! Now, I know some are thinking, I don't have Lupus, why should I care about Benlysta? You don't have Lupus - why are you writing an article about Benlysta. W

[ 3 comments ] | [ read more ]

Benlysta Was Approved And Hope Was Born - A Lupus Patient's Perspective

Benlysta Was Approved And Hope Was Born – A Lupus Patient’s Perspective

March 9, 2011 – I will remember this day, Benlysta was approved and hope was born. I will never forget the day I was diagnosed with Lupus. That was 18 years ago, and I am now 33. For those of you doing the math, that means I have had Lupus over half my life. Right now Lupus is incurable, so I exp

[ 32 comments ] | [ read more ]

Historic Day for Lupus Patients - Benlysta gets FDA approval

Historic Day for Lupus Patients – Benlysta gets FDA approval

  FDA approves Benlysta to treat lupus First new lupus drug approved in 56 years The U.S. Food and Drug Administration today approved Benlysta (belimumab) to treat patients with active, autoantibody-positive lupus (systemic lupus erythematosus) who are receiving standard therapy, includi

[ 7 comments ] | [ read more ]

Historic and Hopeful Day for Patients living with Lupus - FDA Advisory Committee’s Recommendation to Approve Benlysta for Lupus

Historic and Hopeful Day for Patients living with Lupus – FDA Advisory Committee’s Recommendation to Approve Benlysta for Lupus

The U.S. FDA Arthritis Advisory Committee voted 13 to 2 to recommend approvalof the treatment developed by Human Genome Sciences (HGS) and GlaxoSmithKline Tuesday, November 16, 2010 The Lupus Research Institute (LRI) and its National Coalition of state and local lupus organizations are pleased wit

[ 7 comments ] | [ read more ]

Food and Drug Administration (FDA) to Hold Hearing on BENLYSTA® on November 16th

Food and Drug Administration (FDA) to Hold Hearing on BENLYSTA® on November 16th

On November 16, 2010, the Food and Drug Administration (FDA) will hold a hearing to discuss the application to approve BENLYSTA® (belimumab) as a treatment to reduce disease activity in adults with active, autoantibody-positive lupus. If approved, BENLYSTA® will be the first drug to be specif

[ 4 comments ] | [ read more ]

FDA Priority Review Designation for BENLYSTA® First Drug for Lupus in 50 years

FDA Priority Review Designation for BENLYSTA® First Drug for Lupus in 50 years

ROCKVILLE, Md.--(EON: Enhanced Online News)--Human Genome Sciences, Inc. (Nasdaq:HGSI) and GlaxoSmithKline PLC (GSK) today announced that the U.S. Food and Drug Administration (FDA) has granted a priority review designation to BENLYSTA® (belimumab) as a potential treatment for systemic lupus er

[ 4 comments ] | [ read more ]